Evidence map›Paper›PMID 42396066›Full record

ArticleACS omega2026

A Multidimensional Evaluation of Sakuranetin against

Dalete Christine S Souza, Pedro Enrico H Tesser, Erica Fernanda da S Tirelli, Ruqaya Jasim, Monique C Amaro, Rayssa A Cajas, Dion R Brocks, Josué de Moraes, João Henrique G Lago

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dalete Christine S SouzaCenter for Natural and Human Sciences, Federal University of the ABC, São Paulo 09210-180, SP Brazil.
Pedro Enrico H TesserCenter for Natural and Human Sciences, Federal University of the ABC, São Paulo 09210-180, SP Brazil.
Erica Fernanda da S TirelliCenter for Natural and Human Sciences, Federal University of the ABC, São Paulo 09210-180, SP Brazil.
Ruqaya JasimKatz Group Centre for Research, University of Alberta, Edmonton, Alberta T6G 2G5, Canada.
Monique C AmaroCenter for Research on Neglected Diseases, Guarulhos University, São Paulo 07023-070, Brazil.
Rayssa A CajasCenter for Research on Neglected Diseases, Guarulhos University, São Paulo 07023-070, Brazil.
Dion R BrocksKatz Group Centre for Research, University of Alberta, Edmonton, Alberta T6G 2G5, Canada.
Josué de MoraesCenter for Research on Neglected Diseases, Guarulhos University, São Paulo 07023-070, Brazil.ORCID https://orcid.org/0000-0003-1766-7031
João Henrique G LagoCenter for Natural and Human Sciences, Federal University of the ABC, São Paulo 09210-180, SP Brazil.ORCID https://orcid.org/0000-0002-1193-8374

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis is a highly prevalent neglected tropical disease affecting more than 250 million people worldwide and currently relies on praziquantel (PZQ) as the only available treatment. This dependence raises concerns about the long-term sustainability of current control strategies and underscores the urgent need for new anthelmintic agents. In this context, natural products represent an important source of novel bioactive compounds. In the present study, the antischistosomal potential of sakuranetin (SAK), a flavanone isolated from

Identifiers

PMID42396066
PMCPMC13325134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.